HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-144 Cr | ₹-27 Cr | ₹-7.68 Cr | ₹-5.56 Cr | ₹-97 Cr |
What is the latest Cash Flow from Financing Activities ratio of HIKAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-144 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-7.68 Cr |
| Mar2022 | ₹-5.56 Cr |
| Mar2021 | ₹-97 Cr |
How is Cash Flow from Financing Activities of HIKAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-144 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-7.68 Cr | Negative | |
| Mar2022 | ₹-5.56 Cr | Negative | |
| Mar2021 | ₹-97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,422.8 Cr | -3.5% | 1.8% | -43.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.5% |
1.8% |
-43.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses